![Implementing clinical trial data sharing requires training a new generation of biomedical researchers | Nature Medicine Implementing clinical trial data sharing requires training a new generation of biomedical researchers | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-02080-y/MediaObjects/41591_2022_2080_Fig1_HTML.png)
Implementing clinical trial data sharing requires training a new generation of biomedical researchers | Nature Medicine
![Sharing and reuse of individual participant data from clinical trials: principles and recommendations | BMJ Open Sharing and reuse of individual participant data from clinical trials: principles and recommendations | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/7/12/e018647/F1.large.jpg)
Sharing and reuse of individual participant data from clinical trials: principles and recommendations | BMJ Open
![Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing - National Academy of Medicine Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing - National Academy of Medicine](https://nam.edu/wp-content/uploads/2019/06/Box-7.png)
Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing - National Academy of Medicine
![Overview and experience of the YODA Project with clinical trial data sharing after 5 years | Scientific Data Overview and experience of the YODA Project with clinical trial data sharing after 5 years | Scientific Data](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsdata.2018.268/MediaObjects/41597_2018_Article_BFsdata2018268_Fig1_HTML.jpg)
Overview and experience of the YODA Project with clinical trial data sharing after 5 years | Scientific Data
![4 The Clinical Trial Life Cycle and When to Share Data | Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk | The National Academies Press 4 The Clinical Trial Life Cycle and When to Share Data | Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk | The National Academies Press](https://nap.nationalacademies.org/openbook/18998/xhtml/images/img-130.jpg)
4 The Clinical Trial Life Cycle and When to Share Data | Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk | The National Academies Press
![Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing - National Academy of Medicine Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing - National Academy of Medicine](https://nam.edu/wp-content/uploads/2019/06/Box-1.png)
Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data Sharing - National Academy of Medicine
![The obligatory sharing of clinical trial data in the European Union - datenschutz notizen | News-Blog der DSN GROUP The obligatory sharing of clinical trial data in the European Union - datenschutz notizen | News-Blog der DSN GROUP](https://www.datenschutz-notizen.de/wp-content/uploads/2017/09/Blogbeitrag_Stefanie_Wojak_633px_2.jpg)
The obligatory sharing of clinical trial data in the European Union - datenschutz notizen | News-Blog der DSN GROUP
![Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models | Scientific Data Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models | Scientific Data](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41597-023-02436-0/MediaObjects/41597_2023_2436_Fig1_HTML.png)
Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models | Scientific Data
![A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies | BMC Medicine | Full Text A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies | BMC Medicine | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12916-023-03113-0/MediaObjects/12916_2023_3113_Fig1_HTML.png)